Authors' Corner‎ > ‎

Chinazo Cunningham, MD, MS

  1. Roose RJ, Hayashi AS, Cunningham CO. Self-management of injection-related wounds among injection drug users in Washington, D.C. J Addict Dis. 2009;28(1):74-80. PMC2695510
  2. Netherland J, Botsko M, Egan JE, Saxon AJ, Cunningham CO, Finkelstein R, Gourevitch MN, Renner JA, Sohler N, Sullivan LE, Weiss L, Fiellin DA and the BHIVES Collaborative. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009;36(3):244-251. PMC2866292
  3. Cunningham CO, Giovanniello A, Sacajiu G, Li X, Brisbane M, Sohler NL. Inquiries about and initiation of buprenorphine treatment in an inner-city health center. Subst Abuse. 2009 Jul-Sept;30(3):261-2. PMC2746741
  4. Cunningham CO, Doran B, DeLuca J, Dyksterhouse R, Asgary R, Sacajiu G. Routine opt-out HIV testing in an urban community health center. AIDS Patient Care STDS. 2009 Aug;23(8):619-23. PMC2832648
  5. Sohler NL, Li X, Cunningham CO. Gender disparities in HIV healthcare utilization among the severely disadvantaged: Can we determine the reasons? AIDS Patient Care STDS. 2009 Sep;23(9):775-83. PMC2859765
  6. Kunins HV, Sohler NL, Roose RJ, Cunningham CO. HIV provider endorsement of primary care buprenorphine treatment: A vignette study. Fam Med 2009;41(10):722-8. PMC2827924
  7. Sohler NL, Coleman S, Cabral H, Naar-King S, Tobias C, Cunningham CO. Does self-report data on HIV primary care utilization agree with medical record data for socially marginalized populations in the U.S.? AIDS Patient Care STDS. 2009 Oct;23(10):837-43. PMC2859764
  8. Sohler NL, Li X, Kunins HV, Sacajiu G, Giovanniello A, Whitley S, Cunningham CO. Home- versus office-based buprenorphine inductions for opioid-dependent patients. J Subst Abuse Treat. 2010 Mar;38(2):153-9. Epub 2009 Oct 3. PMC2849656
  9. Whitley S, Sohler NL, Kunins HV, Giovanniello A, Li X, Sacajiu G, Cunningham CO. Factors associated with complicated buprenorphine inductions. J Subst Abuse Treat. 2010 Jul;39(1):51-7.
  10. Cunningham CO, Sohler NL, Cooperman NA, Berg KM, Litwin AH, Arnsten JH. Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users. Subst Use Misuse. 2011;46(2-3):218-32.
  11. Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthius PT, Flanigan TP, Cunningham CO, et al. HIV treatment outcomes among HIV-infected opioid dependent patients receiving buprenorphine/naloxone treatment in HIV care setting: Results from a multi-site study. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S22-32.
  12. Fiellin DA, Weiss L, Botsko M, Egan JE, Altice FL, Bazerman L, Chaudhry A, Cunningham CO, et al. Drug treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S33-8.
  13. Sullivan LE, Botsko M, Cunningham CO, Connor PG, Hersh D, Mitty J. Lum PJ, Schottenfeld RS, Fiellin DA. The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S54-61.
  14. Cunningham CO, Giovanniello A, Li X, Kunins HV, Roose RJ, Sohler NL. A comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions. J Subst Abuse Treat. 2011 Feb 17. [Epub ahead of print].